Tryptamine Therapeutics Limited (ASX:TYP)
Australia · Delayed Price · Currency is AUD 0.0310
-0.0010 (-3.13%)
At close: Sep 9, 2025
Tryptamine Therapeutics Market Cap
Tryptamine Therapeutics has a market cap or net worth of 43.20 million as of September 10, 2025. Its market cap has increased by 80.61% in one year.
Market Cap
43.20M
Enterprise Value
40.17M
Revenue
1.58M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.03
Market Cap Chart
Since May 29, 2024, Tryptamine Therapeutics's market cap has increased from 38.06M to 43.20M, an increase of 13.49%. That is a compound annual growth rate of 10.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 9, 2025 | 44.64M | -7.97% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 102.19B |
| Pro Medicus | 31.05B |
| Cochlear | 19.55B |
| Sonic Healthcare | 11.22B |
| Ramsay Health Care | 7.76B |
| Ansell | 4.94B |
| Telix Pharmaceuticals | 4.88B |
| Mesoblast | 2.96B |